Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
107
Views
21
CrossRef citations to date
0
Altmetric
Original Research

The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer

Zhiyao Fan1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Kun Fan1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Yitao Gong1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Qiuyi Huang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Chao Yang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
He Cheng1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Kaizhou Jin1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Quanxing Ni1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
,
Xianjun Yu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-6697-7143
ORCID Icon,
Guopei Luo1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Chen Liu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0001-8155-773X
ORCID Icon show all
Pages 8781-8788 | Published online: 30 Sep 2019

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shengming Deng, Zhiyao Fan, Huanyu Xia, Yitao Gong, Yunzhen Qian, Qiuyi Huang, He Cheng, Kaizhou Jin, Zhiwen Xiao, Guopei Luo, Xianjun Yu & Chen Liu. (2021) Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms. Cancer Management and Research 13, pages 107-115.
Read now

Articles from other publishers (20)

Yuan Shu, Haiqiang Huang, Minjie Gao, Wenjie Xu, Xiang Cao, Xiaoze Jia & Bo Deng. (2023) Lipid Metabolism-Related Gene Markers Used for Prediction Prognosis, Immune Microenvironment, and Tumor Stage of Pancreatic Cancer. Biochemical Genetics 62:2, pages 931-949.
Crossref
Xiaopeng Chen, Zhaohui Chen, Jianyang Guo, Zhe Xiu & Huangxiang Chen. (2024) Preoperative plasma fibrinogen and C-reactive protein/albumin ratio as prognostic biomarkers for pancreatic carcinoma. Frontiers in Oncology 14.
Crossref
Burcu Baran, Nur A Yetkin, Nuri Tutar, Zeynep Türe, Fatma S Oymak & İnci Gülmez. (2024) The Role of Sequentially Monitored Laboratory Values and Inflammatory Biomarkers in Assessing the Severity of COVID-19. Cureus.
Crossref
Barbara Morawin, Anna Tylutka, Filip Bielewicz & Agnieszka Zembron-Lacny. (2023) Diagnostics of inflammaging in relation to sarcopenia. Frontiers in Public Health 11.
Crossref
Yimin Shen, Yuanyuan Li, Zhou Wang, Wei Xu, Wenjie Wang & Xiao Chen. (2023) The prognostic value of FAR and a novel FAR-CA125 score in resectable gastric signet ring cell carcinoma patients. Journal of Cancer Research and Clinical Oncology.
Crossref
Christopher C. M. Neumann, François Schneider, Georg Hilfenhaus, Loredana Vecchione, Matthäus Felsenstein, Jana Ihlow, Dominik Geisel, Steffen Sander, Johann Pratschke, Sebastian Stintzing, Ulrich Keilholz & Uwe Pelzer. (2023) Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade. Cancers 15:8, pages 2367.
Crossref
Satoshi Kobayashi, Shun Tezuka, Yui Yamachika, Shotaro Tsunoda, Shuhei Nagashima, Yuichiro Tozuka, Taito Fukushima, Manabu Morimoto, Makoto Ueno, Junji Furuse & Shin Maeda. (2023) FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study. BMC Cancer 23:1.
Crossref
Li Wang, Xianfei Qin, Yu Zhang, Shouyu Xue & Xicheng Song. (2023) The prognostic predictive value of systemic immune index and systemic inflammatory response index in nasopharyngeal carcinoma: A systematic review and meta-analysis. Frontiers in Oncology 13.
Crossref
Naoko Nomoto, Shinichi Tate, Makoto Arai, Shinji Iizaka, Chisato Mori & Kenichi Sakurai. (2022) Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer. Nutrients 14:23, pages 5183.
Crossref
Alexia Roux, Valentin David, Sylvia Bardet M, Emilie Auditeau, Sylvaine Durand Fontanier & Abdelkader Taibi. (2022) Predictive value of C-reactive protein levels for the early and later detection of postoperative complications after cytoreductive surgery and HIPEC. Frontiers in Oncology 12.
Crossref
Masami Miki, Lingaku Lee, Terumasa Hisano, Rie Sugimoto & Masayuki Furukawa. (2021) Loss of adipose tissue or skeletal muscle during first‐line gemcitabine/nab‐paclitaxel therapy is associated with worse survival after second‐line therapy of advanced pancreatic cancer. Asia-Pacific Journal of Clinical Oncology 18:5.
Crossref
Baibei Li, Huachu Deng, Biao Lei, Leijie Chen, Xinyuan Zhang & Dingran Sha. (2022) The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis. Frontiers in Oncology 12.
Crossref
Anna Badowska-Kozakiewicz, Marta Fudalej, Daria Kwaśniewska, Marek Durlik, Anna Nasierowska-Guttmejer, Agata Mormul, Emilia Włoszek, Aleksandra Czerw, Tomasz Banaś & Andrzej Deptała. (2022) Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma—Prevalence, Clinicopathological Variables, and Clinical Outcomes. Cancers 14:12, pages 2840.
Crossref
Hirotsugu Maruyama, Kojiro Tanoue, Yuki Ishikawa-Kakiya, Masafumi Yamamura, Akira Higashimori, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, Shuhei Hosomi, Fumio Tanaka, Noriko Kamata, Yasuaki Nagami, Koichi Taira, Go Ohira, Kenjiro Kimura, Ryosuke Amano & Yasuhiro Fujiwara. (2022) Clinical Implication of Preoperative C-Reactive Protein/Albumin Ratio in Malignant Transformation of Intraductal Papillary Mucinous Neoplasm: A Propensity Score Analysis. Diagnostics 12:2, pages 554.
Crossref
N Yilmaz, F Tosun, E Comert, M Duran & VD Tuna. (2022) The Relationship of CRP/Albumin ratio level and prognosis in pregnant COVID-19 patients. Nigerian Journal of Clinical Practice 25:10, pages 1745.
Crossref
Faysal Saylik, Tayyar Akbulut & Safak Kaya. (2021) Can C-Reactive Protein to Albumin Ratio Predict In-Hospital Death Rate Due to COVID-19 in Patients With Hypertension?. Angiology 72:10, pages 947-952.
Crossref
Yueying Li, Yajun Chen, Yaqi Zeng, Jie Dong, Chunlei Li, Yingjie Jia, Yonghua Zhao & Kun Wang. (2021) Enteral Nutrition Combined with Improved-Sijunzi Decoction Shows Positive Effect in Precachexia Cancer Patients: A Retrospective Analysis. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-8.
Crossref
Misako Higashida-Konishi, Keisuke Izumi, Satoshi Hama, Hiroshi Takei, Hisaji Oshima & Yutaka Okano. (2021) Comparing the Clinical and Laboratory Features of Remitting Seronegative Symmetrical Synovitis with Pitting Edema and Seronegative Rheumatoid Arthritis. Journal of Clinical Medicine 10:5, pages 1116.
Crossref
Mahmut Buyuksimsek, Mehmet Mutlu Kidi, Ali Ogul, Cem Mirili & Semra Paydas. (2020) The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen. Journal of Gastrointestinal Cancer 52:1, pages 249-255.
Crossref
Qinfen Xie, Lidong Wang & Shusen Zheng. (2020) Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis. Dose-Response 18:2, pages 155932582093129.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.